A world tour of measures to stop SF medical products at governmental level
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Presentation
- By: MOSS, Robert (FIP Hosp Pharm Section, Aerdenhout, Netherlands)
- Co-author(s): Robert Moss
Substandard and Falsified (SF) medicines are a threat to public health. Worldwide, governments are setting up systems to safeguard the integrity of the supply chain. Different approaches are chosen to adress this issue. They vary from full track-and-trace systems, through pharmacy based verifcation to having patients verify the medication using.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.